Data Foundry

Drug recalls 2018

Metoprolol Succinate Extended-Release Tablets — Class II drug recall D-0727-2018

Terminated recall by Dr. Reddy's Laboratories, Inc., reported 2018-05-16, distributed nationwide. Presence of Foreign Tablets/Capsules: One foreign tablet identified as Clopidogrel 75 mg was found in a 100 co

Recall numberD-0727-2018
Product typeDrug
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmDr. Reddy's Laboratories, Inc., Princeton, NJ, United States
Recall initiated2018-04-23
Classified2018-05-09
Reported by FDA2018-05-16
Terminated2020-12-14
DistributedNationwide (US)
Quantity8,160 bottles
NDC55111-0468, 55111-0468-01, 55111-0468-05, 55111-0468-30, 55111-0468-60, 55111-0468-78, 55111-0468-79, 55111-0469, 55111-0469-01, 55111-0469-05, 55111-0469-30, 55111-0469-60, 55111-0469-78, 55111-0469-79
Lot numbersC706254

Product

Metoprolol Succinate Extended-Release Tablets, USP, 100 mg, 100 Tablets bottle, Rx only, Manufactured by: Dr. Reddy's Laboratories Limited Bachupally-500 090 India\ NDC 55111-468-01

Reason for recall

Presence of Foreign Tablets/Capsules: One foreign tablet identified as Clopidogrel 75 mg was found in a 100 count bottle of Metoprolol Succiante Extended-Release Tablets.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0727-2018. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.